Product Detail

Product Detail

DT50

Key Features
  • BATHLESS - Extremely short heating times with patented induction heating technology
  • TEMPERATURE - Permanent temperature monitoring without any delay at test start
  • TEST START - Automated test start when target temperature has been reached
  • DETECTION - 100% automatic end-point detection when tablets are disintegrated
  • PROTOCOL - Record and protocol disintegration times of individual tablet automatically
  • BASKETS - Basket type and serial number are automatically recognized & protocolled
  • MODULAR - Flexibly add stations to your testing system as capacities increase
  • RESIDUAL HEIGHT - Individually programmable for capsules and other dosage forms
Category

Share This Items :

Free installation

Lorem ipsum dolor sit amet, consectetur

FREE SHIPPING

Lorem ipsum dolor sit amet, consectetur

Product Description

The bathless DT50 sets new standards in fast and user-friendly operation. Induction heating technology reduces heating times to only 3 – 5 minutes and eliminates unproductive cleaning tasks. Proven automatic end-point detection makes visual monitoring by the operator a thing of the past.

Related Products

Related Products

SDT-L : 14-vessel dissolution tester

Compact, space-efficient comparative dissolution tester with 14 vessels designed for simultaneously testing two formulations with a single instrument under 100% identical conditions.

MP xtend

The universal SmartFill™ dispensing head of the MP Xtend™ media preparation station fits securely on any vessel type and brand. Its ergonomic design enables users to quickly and accurately fill multiple vessels at a central location in your lab. Alternatively it is possible to dispense directly into the vessels of any dissolution bath without having to remove the glassware.

USP4

Sometimes referred to as the “Swiss Army Knife”, flow-through cells allow dissolution testing of virtually all dosage forms. SOTAX was the first manufacturer to develop a standardized flow-through dissolution tester and has ever since helped pharmaceutical companies all over the world in designing robust flow-through methods – and new flow-through cells for novel dosage forms.